Speaker Details

Benjamin Kaffenberger, MD, MS, FAAD

Benjamin Kaffenberger, MD, MS, FAAD

Ohio State university

BIOGRAPHY

residency at Ohio State. His clinical interests are in hospital based dermatology, autoimmune skin disease, graft-versus-host disease, and drug reactions. He has research interests in hospital dermatology outcomes, imaging techniques and analysis in dermatology, teledermatology/patient access to dermatology, and clinical trials. His research has been funded by the National Psoriasis Foundation, American Acne and Rosacea Society, Dermatology Foundation, National Rosacea Society, the Ohio Department of Medicaid, and the NIAMS and NIAID. In his spare time, he enjoys music, being outdoors, fishing, home improvement, cross-country skiing, and spending time with his wife and four children.

SESSIONS

F007 The Morbilliform Eruption: Differentiation and Treatment of Viral, Low-Risk Drug, Severe Cutaneous Adverse Reactions, and GVHD
Mar 19, 2027 • 9:00 AM - 11:00 AM
S017 Consultative Dermatology for the Hospitalized Patient
Mar 20, 2027 • 9:00 AM - 12:00 PM
F058 New Drugs, New Rashes: An Update on Cutaneous Drug Eruptions
Mar 21, 2027 • 3:30 PM - 5:30 PM

DISCLOSURES

Almirall – Consultant (1099 relationship)(Honoraria); Boehringer Ingelheim – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Dermatology Foundation – Investigator(Grants/Research Funding); Eli Lilly and Company – Consultant (1099 relationship)(Honoraria); HCW Biologics – Investigator(Grants/Research Funding); InflaRx – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Janssen Biotech – Investigator(Grants/Research Funding); Leo Pharma – Investigator(Grants/Research Funding); National Comprehensive Cancer Network – Speaker(Honoraria); Pfizer Inc. – Data Safety Monitoring Board(Fees); Protillion Biosciences – Consultant (1099 relationship)(Stock Options);